Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) just unveiled an update.
Shandong Weigao Group Medical Polymer Company Limited has announced the composition of its board of directors, highlighting the roles and functions of each member. This announcement provides clarity on the company’s governance structure, potentially impacting its strategic direction and stakeholder confidence.
The most recent analyst rating on (HK:1066) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited is a joint stock limited company incorporated in the People’s Republic of China. It operates in the medical industry, focusing on the production of medical polymer products.
Average Trading Volume: 15,613,509
Technical Sentiment Signal: Buy
Current Market Cap: HK$28.4B
For detailed information about 1066 stock, go to TipRanks’ Stock Analysis page.